Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Acta Clinica Croatica|February 28, 2018
Drug-Induced Photosensitivity - a Continuing Diagnostic ChallengeLiborija Lugović-Mihić, Tomislav Duvančić, Iva Ferček, et al.
Acta Dermatovenerologica Croatica : ADC|September 23, 2019
Melanoma Development: Current Knowledge on Melanoma PathogenesisLiborija Lugović-Mihić, Diana Ćesić, Petra Vuković, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 13, 2019
Importance of ovarian tissue cryopreservation in fertility preservation and anti-aging treatmentPetra Vuković, Miro Kasum, Darko Orešković, et al.
Critical Reviews in Oncology/Hematology|December 17, 2020
Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variantsPetra Vuković, Fedro Alessandro Peccatori, Claudia Massarotti, et al.
Bosnian Journal of Basic Medical Sciences|January 24, 2021
Expression of NEDD9 and connexin-43 in neoplastic and stromal cells of gastric adenocarcinomaIvan Lerotić, Petra Vuković, Davor Hrabar, et al.
Acta Clinica Croatica|August 1, 2019
FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCERPetra Vuković, Miro Kasum, Jelena Raguž, et al.
IUBMB Life|March 6, 2020
HbA1c in patients with intracranial meningiomas WHO grades I and II: A preliminary studyDarko Orešković, Fadi Almahariq, Ana Majić, et al.
International Journal of Molecular Sciences|June 26, 2025
Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Subgroup Insights from an Interventional StudyMiloš Mitrović, Verica Stanković Popović, Sanja Erceg, et al.
Nature Cancer|June 8, 2026
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trialPeter Schmid, Seock-Ah Im, Zbigniew Nowecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Durvalumab Plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast CancerPeter Schmid, Cynthia X Ma, Yeon Hee Park, et al.
Pageof 1